The impact of tolvaptan on the incidence of contrast-induced acute kidney injury and long-term progn...
The impact of tolvaptan on the incidence of contrast-induced acute kidney injury and long-term prognosis in high-risk patients after coronary intervention
About this item
Full title
Author / Creator
Publisher
England: Taylor & Francis
Journal title
Language
English
Formats
Publication information
Publisher
England: Taylor & Francis
Subjects
More information
Scope and Contents
Contents
To investigate the effect of low-dose tolvaptan combined with hydration on the incidence of contrast-induced acute kidney injury (CI-AKI) and prognosis in high-risk patients undergoing coronary angiography or intervention.
This single-center, randomized controlled clinical trial (ChiCTR2000028834) enrolled 232 patients scheduled for elective cor...
Alternative Titles
Full title
The impact of tolvaptan on the incidence of contrast-induced acute kidney injury and long-term prognosis in high-risk patients after coronary intervention
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_2e83f5ce68374445acb0e5104dc56e7c
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2e83f5ce68374445acb0e5104dc56e7c
Other Identifiers
ISSN
0886-022X,1525-6049
E-ISSN
1525-6049
DOI
10.1080/0886022X.2025.2498091
